default author photo

Mary Linton B. Peters

Harvard University - Massachusetts General Hospital

55 Fruit Street Boston

Boston, MA 02114

United States

SCHOLARLY PAPERS

1

DOWNLOADS

20

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Survival Benefit of Universal Homologous Recombination Deficiency Testing in Ovarian Cancer Patients

Number of pages: 23 Posted: 16 Jun 2026
Stanford University, affiliation not provided to SSRN, affiliation not provided to SSRN, Tufts University - Tufts Medical Center, Columbia University College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons, Harvard University - Dana-Farber Cancer Institute, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Tufts University - Tufts Medical Center and affiliation not provided to SSRN
Downloads 20

Abstract:

Loading...

decision analysis, advanced ovarian cancer, homologous recombination deficient tumors, poly(ADP-ribose) polymerase inhibitors